Institute of Inflammation and Ageing From basic science to clinical trials, we cover every aspect of research into inflammation, the role it plays in ageing and the response to trauma.
News Rugby study identifies new method to diagnose concussion using saliva A University of Birmingham-led study of top-flight UK rugby players – carried out in collaboration with the Rugby Football Union (RFU), Premiership Rugby, and Marker Diagnostics – has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings.
News University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb
Posted 14 May 2021 New study into paediatric intensive care paves the way for improving care for critically ill children A new study carried out in collaboration with the University of Birmingham has identified factors that increase the likelihood of critically ill children needing life-saving CPR.
Posted 06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
Posted 21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
Posted 30 March 2021 Vitamin D deficiency linked to metabolic changes in patients with lupus Patients with lupus are more likely to have metabolic syndrome and insulin resistance – both factors linked to heart disease – if they have lower vitamin D levels, a new study reveals.
Posted 23 March 2021 Rugby study identifies new method to diagnose concussion using saliva A study of top-flight UK rugby players has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings.
Posted 09 March 2021 Research aims to find new treatment for secondary brain damage A new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage has been launched by the Universities of Birmingham and Cambridge.